Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Injectable medications have shown slightly higher weight loss efficacy, but the flexibility of oral options like oral Wegovy and Foundayo can make them more appealing
Semaglutide is part of the GLP-1 agonists group, a drug used to treat type 2 diabetes and obesity-related problems
Dry mouth during semaglutide treatment may result from indirect factors such as reduced fluid intake due to appetite suppression, dehydration from gastrointestinal side effects, or concurrent medications that cause xerostomia rather than a direct effect of semaglutide itself
GLP-1 Medications and Heart Protection: cardiovascular outcome evidence for GLP-1 therapy
Analysis of the FDAs adverse event database found that semaglutide had the highest odds ratio for reported constipation among GLP-1 medications, which matters if you are choosing between options or considering switching
Brett, MD Medical Reviewer Ross Wollen Author Ross Wollen joined Everyday Health in 2021 and now works as a senior editor, often focusing on diabetes, obesity, heart health, and metabolic health
US$ 28.15
US$ 26.39
US$ 25.28
US$ 23.94
US$ 21.20
